MetaCap

Who Owns Praxis Precision Medicines Stock?

NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

300.43-10.47 (-3.37%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
127.09%
Institutional holders
471
  • Institutions 99.7%
  • Insiders 0.3%
  • Public and other 0.0%

Who owns Praxis Precision Medicines stock?

Institutional investors own about 127.1% of Praxis Precision Medicines's shares, spread across 471 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.28% of PRAX.

The largest institutional holders are Janus Henderson Group Ltd. (12.34%), FMR, LLC (9.44%) and Blackrock Inc. (7.99%). Together, the top 10 institutions control 64.5% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their PRAX positions and 7 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of PRAX

Praxis Precision Medicines top institutional holders
InstitutionShares% HeldChange
Janus Henderson Group Ltd.3.45M12.34%-0.3%
FMR, LLC2.64M9.44%+13.8%
Blackrock Inc.2.23M7.99%-2.6%
Perceptive Advisors Llc2.02M7.24%-0.6%
Baker Bros. Advisors, LP1.75M6.27%0.0%
Orbis Allan Gray Ltd1.36M4.87%-11.1%
Vanguard Portfolio Management LLC1.30M4.67%-2.3%
Vanguard Capital Management LLC1.23M4.40%-0.5%
State Street Corporation1.04M3.74%+1.8%
Adage Capital Partners GP L.L.C.981.52K3.51%-3.3%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of PRAX

Praxis Precision Medicines top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund885.41K3.17%
iShares Trust-iShares Russell 2000 ETF650.75K2.33%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund639.58K2.29%
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF427.95K1.53%
Fidelity Select Portfolios-Select Biotechnology Portfolio409.43K1.46%
VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund405.02K1.45%
JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund383.83K1.37%
JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund358.09K1.28%
Manager Directed Portfolios-Hood River Small-Cap Growth Fund308.60K1.10%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund300.87K1.08%

Frequently asked questions

Who is the largest shareholder of Praxis Precision Medicines?

Janus Henderson Group Ltd. is the largest institutional shareholder of PRAX, owning 12.34% of shares outstanding (3.45M shares) as of its latest 13F filing.

What percentage of Praxis Precision Medicines is owned by institutions?

Institutions own about 127.1% of PRAX shares and 127.4% of the public float.

How much of Praxis Precision Medicines do insiders own?

Insiders, such as officers and directors, own about 0.28% of PRAX shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related